Neuronetics PE Ratio 2017-2019 | STIM
Current and historical p/e ratio for Neuronetics (STIM) from 2017 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Neuronetics PE ratio as of November 12, 2019 is 0.00.
|Neuronetics PE Ratio Historical Data
||TTM Net EPS
||Medical Instruments Manufacturing
Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics, Inc. is based in Malvern, United States.